Funding Opportunity Number: RFA-DK-27-147
Issuing agency: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Application deadline: September 30, 2026 at 5:00 PM local time of the applicant organization.
Funding: NIDDK intends to commit $3,300,000 in FY2027 for one award. Application budgets may not exceed $2,200,000 in direct costs per year, exclusive of consortium or subcontract F&A costs. The maximum project period is five years. Cost sharing is not required.
Purpose: This single-source U24 continues the Integrated Islet Distribution Program (IIDP), which provides high-quality human islet resources, quality control, phenotyping and genotyping, data services, distribution infrastructure, and related research-community support for diabetes research.
Eligibility restriction: Only Beckman Research Institute/City of Hope, specifically the eligible PI/PDs associated with the award issued under RFA-DK-20-509, may apply. Foreign organizations, foreign components, and foreign collaborations described as ineligible in the NOFO are not permitted.
Atlas assessment: This is a highly relevant diabetes research infrastructure opportunity but a closed single-source continuation. It is not an applicant-outreach opportunity and is not a Dr. Miltie direct-vendor path. Recommended posture: Restricted Single-Source / City of Hope Only / No Broad Routing.
Atlas score: 82/100 for healthcare relevance; pursuit eligibility is restricted.